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Pregnancy/Preeclampsia
Multi-Fetal Pregnancy, Preeclampsia, and
Long-Term Cardiovascular Disease
Lina Bergman , Paliz Nordlöf-Callbo, Anna Karin Wikström, Jonathan M. Snowden,
Susanne Hesselman, Anna Karin Edstedt Bonamy, Anna Sandström
Abstract—This Swedish register-based cohort study determined the separate and joint contribution of preeclampsia and
multi-fetal pregnancy on a woman’s risk of cardiovascular disease (CVD) later in life. The study included 892 425 first
deliveries between 1973 and 2010 of women born 1950 until 1971, identified in the Swedish Medical Birth Register.
A composite outcome of CVD was retrieved through linkage with the National Patient and Cause of Death Registers.
Cox proportional hazard regression was used to assess the risk of CVD in women who had preeclampsia in a singleton
or multi-fetal pregnancy, adjusting for potential confounders, and presented as adjusted hazard ratios. Compared with
women who had a singleton pregnancy without preeclampsia (the referent group), women with preeclampsia in a
singleton pregnancy had an increased risk of CVD (adjusted hazard ratio 1.75 [95% CI, 1.64–1.86]). Women who had
a multi-fetal pregnancy without or with preeclampsia did not have an increased risk of future CVD (adjusted hazard
ratios 0.94 [95% CI, 0.79–1.10] and 1.25 [95% CI, 0.83–1.86], respectively). As opposed to preeclampsia in a first
singleton pregnancy, preeclampsia in a first multi-fetal pregnancy was not associated with increased risk of future
CVD. This may support the theory that preeclampsia in multi-fetal pregnancies more often occurs as a result of the
larger pregnancy-related burden on the maternal cardiovascular system and excessive placenta-shed inflammatory
factors, rather than the woman’s underlying cardiovascular phenotype.  (Hypertension. 2020;76:167-175. DOI:
10.1161/HYPERTENSIONAHA.120.14860.) Data Supplement

•
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P

reeclampsia is a pregnancy-specific hypertensive disorder
that affects 2% to 8% of all pregnancies.1 Women with previous preeclampsia have a 2-fold higher risk of cardiovascular
morbidity and mortality later in life.2 Additional complications
to preeclampsia such as miscarriage, preterm birth, and intrauterine growth restriction synergistically increase the association to later cardiovascular disease (CVD).3–5
Preeclampsia causation is complex and multi-factorial.
Preeclampsia and CVD share many common risk factors, such
as hypercholesterolemia, obesity, increasing age, and diabetes
mellitus.6,7 Compared with women without preeclampsia, the
cardiovascular function in women who later develop preeclampsia has been found to be different before pregnancy or
altered in early pregnancy. In these studies, women that later
developed preeclampsia had a higher peripheral vascular resistance and a lower cardiac output compared with women
with subsequent normal pregnancies.8,9 It is debated whether
preeclampsia might be caused by failure of adaptation of the
cardiovascular system secondary to the increased demand

from the maternal system and the fetoplacental unit, leading
to a state of intermittent placental hypoxia and subsequent endothelial dysfunction secondary to hypoxic debris from the
placenta.8 This maladaptation could reveal an underlying deficiency in the cardiovascular system already present at the
time of pregnancy, putting these women at higher risk for
CVD later in life.8 Together, this reinforces the hypothesis of
preeclampsia as a cardiovascular stress test during pregnancy.
Because preeclampsia is an adverse pregnancy outcome with
a heterogenous pathophysiology, this hypothesis could hold
true for some women but perhaps not for all. Some also argue
that preeclampsia in itself is an insult to the cardiovascular
system during pregnancy also in women without predisposition for CVD and that the insult as such causes the increased
long-term risks for CVD in these women.10
Women with multi-fetal pregnancies are at about 3 to
4 times higher risk of preeclampsia,11,12 also when adjusted
for potential confounders.13 The incidence of preeclampsia
among women with multi-fetal pregnancies in Scandinavia is
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between 10% and 18%,12–14 but these pregnancies are often
excluded from preeclampsia studies.7 It is likely that preeclampsia cause in multi-fetal pregnancies differs from other
preeclampsia subtypes. Multi-fetal pregnancies pose a higher
load on the cardiovascular system, partly manifested by
higher cardiac output and lower total vascular resistance.15
The underlying cause of preeclampsia in women with multifetal pregnancy could be more specific to pregnancy itself (eg,
higher demand on the cardiovascular system from increased
syncytiotrophoblast stress from one larger placenta or 2 placentas more rapidly stressed during pregnancy), rather than
the preexisting cardiovascular risk factors described above.
Data on placental histopathology from pregnancies complicated by preeclampsia show significantly lower rates of maternal and fetal vascular lesions in multi-fetal compared with
singleton pregnancies, supporting the hypothesis of different
mechanisms behind the disease.16 Multi-fetal pregnancy itself
is not a risk factor for underlying maternal cardiovascular pathology; data show that women with multi-fetal pregnancies
without preeclampsia do not experience an increased risk of
later CVD compared with women with singleton pregnancies without preeclampsia.14 Theoretically, women with preeclampsia in a multi-fetal pregnancy could run a lower risk
of later CVD compared with women with preeclampsia complicating a singleton pregnancy if preeclampsia in multi-fetal
pregnancy is the result of the increased demand on the cardiovascular system rather than an underlying disadvantageous
cardiovascular profile. To the best of our knowledge, there are
no studies investigating the long-term cardiovascular outcome
after a multi-fetal pregnancy complicated by preeclampsia.
The aim of this study was to further explore the longterm effects of preeclampsia by investigating if women with
multi-fetal pregnancies complicated by preeclampsia have an
increased risk of CVD compared with women with singleton
pregnancies without preeclampsia. This would help to personalize follow-up and interventions after a pregnancy complicated by preeclampsia.

Methods
The data that support the findings of this study are available from the
corresponding author on reasonable request.

Data Sources
The study population was derived from the Swedish Medical Birth
Register (MBR) and was individually linked to other national population-based registers held by the National Board of Health and Welfare
(https://www.socialstyrelsen.se) and Statistics Sweden (https://www.
scb.se), using the person unique identification number assigned to
each citizen at birth or emigration to Sweden (Figure 1).17 The MBR
includes >98% of all deliveries in Sweden since 1973. The register
includes prospectively collected information on demographic data,
reproductive history, and information from the pregnancy, delivery,
and neonatal period using standardized prenatal, obstetric, and neonatal records.18 Diagnoses classified according to the Swedish version
of the International Classification of Diseases (ICD) (ICD-8 until
1986, ICD-9 between 1987 and 1996, and ICD-10 from 1997 and
onwards) for the mother and the infant at discharge from the delivery
hospital are further registered.
The Swedish Patient Register was established in 1964 (nationwide since 1987) and includes dates of hospital admission and ICD
codes on in-patients. Since 2001, the register also includes information on outpatient visits in specialized health care.19 Further linkage

to the Swedish Cause of Death Register20 and to the Register of Total
Population for information on migration to and from Sweden.21 From
the Education Register and the Income Register, information on disposable household income and the highest achieved level of education in the were included (Figure 1).

Study Population
The source population included all women born in Sweden from
January 1, 1950, until December 31, 1971, with deliveries in the MBR
from January 1, 1973, to December 31, 2010 (n=2 120 297; Figure 1).
After exclusions, the study population consisted of 892 425 nulliparous women who were living in Sweden, with singleton or multi-fetal
pregnancies, without an existing diagnosis of CVD (ischemic heart
disease, heart failure, or cerebrovascular disease according to ICD
diagnoses defined in Table S1 in the Data Supplement) at start of follow-up 3 months after birth (Figure 1).

Exposure Variables
The exposure was defined as a combination of maternal diagnosis of
preeclampsia during the first pregnancy (yes/no) and plurality of the
pregnancy (ie, singleton or multi-fetal). The key exposure category
was multi-fetal pregnancies with preeclampsia (motivated by our hypothesis about normal long-term CVD risk in these women; represented as Box D in Figure 1). The reference category, representing
women with normal long-term cardiovascular risk, was women with
a first singleton pregnancy without preeclampsia (Box A in Figure1).
The other preeclampsia/plurality combinations were also studied,
to paint a fuller picture of long-term CVD risk of this population.
Women with preeclampsia complicating a singleton pregnancy (Box
B, Figure 1) and women with multi-fetal pregnancies without preeclampsia (Box C, Figure 1) were also compared with the referent
group of singleton pregnancies without preeclampsia. Preeclampsia
was defined by corresponding ICD-8, -9, or -10 codes of preeclampsia and superimposed preeclampsia registered in the MBR (defined in Table S1 in the Data Supplement). Information on singleton
or multi-fetal pregnancy was retrieved from the delivery record.

Covariates
We sought to control for key covariates that may be associated with
both preeclampsia in first pregnancy and plurality, as well as longterm CVD risk. These potential confounders included maternal
sociodemographic factors and health factors. Given the long study
period required to track women’s development of CVD over time
with sufficient statistical power, we included data from many eras
of data collection. Through the years, variables have been added
to the MBR, for example, smoking during pregnancy (in 1987),
body mass index (in 1992), and assisted reproductive technology
(in 1985). Therefore, some covariates were possible to take into
account across the whole study period and others only for a restricted time of the study period.

From 1973 and Onwards

Information on date of birth, maternal age at delivery, and gestational
length at delivery was retrieved from the MBR. Chronic hypertension
before first birth data was retrieved from the MBR, reported as checkboxes in the standardized antenatal care record or as ICD codes coded
during pregnancy (Table S1). The highest level of education for the
mother was obtained from the Education Register and categorized as
9 years of schooling or less, 10 to 12 years of schooling, and 13 years
or more, achieved in 2011 (for all women in the study population).

From 1987 and Onwards

Self-reported information on infertility duration and daily cigarette
smoking or not in early pregnancy was retrieved from the standardized antenatal record in the MBR. The household’s disposable income in the years of 1990, 1995, 2000, 2005, and 2011 was retrieved
from the Income Register. The disposable household income for all
women was categorized into tertiles of the distribution of each of the
year. The 2 years closest to birth was used for each woman, and the
highest tertile of these was used (eg, if giving birth in 1998, the tertile
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Figure 1. Flowchart of the study population and register linkages, with births in Sweden 1973–2010.

of disposable income in 1995 and in 2000 was used, and the woman
was categorized according to the highest tertile; for births before
1995 the disposable income in 1990 and 1995 was used).
Downloaded from http://ahajournals.org by on June 19, 2020

From 1995 and Onwards

Body mass index (kg/m2) was collected from the first attendance to
antenatal care, occurring before 13 weeks of gestation for 90% of
women in Sweden22 and was divided according to the World Health
Organization’s classification.23 The standardized antenatal record further contains information on assisted reproductive technology and
concurrent diseases, kidney disease, and systemic lupus erythematosus, collected from check-boxes, diabetes mellitus, collected from
check-boxes, and ICD codes and categorized as no diabetes mellitus,
pregestational (type I and II) diabetes mellitus, and gestational diabetes mellitus (Table S1).

Outcome Variables
CVD event was defined as diagnosis of, or underlying cause of death
due to, one of the 3 groups of diagnosis of ischemic heart disease,
heart failure, or cerebrovascular disease, whichever occurred first in
the case of multiple morbidities. Chronic hypertension was not part
of the CVD outcomes since ICD diagnoses in the primary health care
centers are not available. Diagnoses with corresponding ICD codes
are defined in Table S1. To minimized capture of false-positive outcome (eg, due to a code being recorded for diagnostic testing rather
than confirmed case) diagnosis of CVD was defined as the first of (1)
one ICD code of CVD in the inpatient register or (2) one ICD code
of CVD in the outpatient, and within 1 year one ICD code in the
inpatient register (using the date from the outpatient visit) or (3) 2
codes in the outpatient register within 1 year (using the date from the
first visit). Information on death due to CVD was retrieved from ICD
codes in the cause of death register.

Statistical Methods
Descriptive statistics were presented with mean, medians, SD, and
frequencies, comparing between our 4 exposure groups defined by
preeclampsia and plurality, using the Pearson χ2 test for categorical
data and the Student t test for mean of continuous variables. To maximize power and to make use of the full data, we conducted analyses

in the population of women with deliveries from 1973 to 2010, 1987
to 2010, and 1995 to 2010.
Data were analyzed using time-to-event methods for the population of women giving birth 1973 to 2010 and to control for important
covariates that only become available later, we also conducted timerestricted analyses among women giving birth 1987 to 2010. The
confounders were chosen by a priori knowledge and in addition by
availability in the registers. Some variables such as body mass index
were only available from 1995 and are presented in Table S2 to give
the most detailed picture possible of the study population, but there
were no time-to-event analyses of the restricted population of deliveries 1995 to 2010 due to small groups.
The event of interest was the first CVD event during follow-up.
Time at risk was accumulated from entry into the cohort (maternal
age at 3 months after the first delivery) until CVD event or censoring
(maternal age at emigration, death from other cause, or last day of
follow-up, December 31, 2011). Attained age was used as the underlying time scale for survival analysis, reflecting that this is the time
scale that most immediately affects risk of CVD.
The exposure was investigated as a categorical variable (multifetal pregnancy with preeclampsia, singleton pregnancy with preeclampsia, multi-fetal pregnancy without preeclampsia, all compared
with singleton pregnancy without preeclampsia).
To investigate possible associations between the exposure and
CVD incidence, we used the Kaplan-Meier curves and Cox proportional hazard models, yielding hazard ratios (HR) with 95% CIs. The
proportional hazard assumption was formally assessed by using the
Schoenfeld and scaled Schoenfeld residuals. Assumption testing suggested that chronic hypertension before first birth did not satisfy the
assumption of proportionality.
In the main analysis of women giving birth 1973 until 2010,
Kaplan-Meier curves were performed for the total population and
were stratified by age at the end of follow-up (<50 years and 50
years or older), to explore the risk of right censoring. The Cox proportional hazard models were analyzed unadjusted and adjusted
for maternal age at delivery (in addition to age as underlying time
scale), chronic hypertension before first birth, level of education,
and time period of birth. In the analysis of the restricted study population giving birth from 1987 to 2010, HRs were additionally
adjusted for tertiles of disposable household income, infertility
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duration, and daily smoking in early pregnancy. In sensitivity analyses, analyses were conducted stratified by chronic hypertension,
rather than adjusting for these in the Cox regression to account for
the possible nonproportionality.
Statistical analyses were performed using the SAS software version 9.4. and STATA software version 14.
This study was approved by the Regional Ethical Review Board
in Stockholm, Sweden (IRB/KI 2012/1325-31/3).

Results
Maternal Characteristics
When comparing women with multi-fetal pregnancies to
women with singleton pregnancies, women with multi-fetal
pregnancies were older, had a shorter mean gestational length,
a larger proportion had higher household disposable income
and a higher level of education than women with singleton
pregnancies. The proportion of multi-fetal pregnancies over
time was higher during the latter years of the study period
(Tables 1 and 2).
Comparing women without and with preeclampsia within
plurality (ie, within singleton and within multiples), suggested

that preeclampsia phenotypes did differ by plurality of the
first pregnancy. Women with singleton pregnancies and preeclampsia had a shorter duration of pregnancy, a lower level
of maternal education, a lower household disposable income,
more often pregestational diabetes mellitus, a longer duration
of infertility, and more often had infertility treatment than
women with singleton pregnancies without preeclampsia. In
contrast, women with preeclampsia complicating a multi-fetal
pregnancy had a longer duration of pregnancy, a higher maternal education and less commonly had pregestational diabetes mellitus as compared to multi-fetal pregnancies without
preeclampsia (Tables 1 and 2 and Table S2).
Shared risk factors for preeclampsia in both singleton and
multi-fetal pregnancies were higher maternal age, higher body
mass index, and presence of gestational diabetes mellitus. A
shared protective factor was smoking.

Time to CVD
Duration of follow-up (ie, time from 3 months after giving
birth to incident CVD or censoring) ranged from 9 months to

Table 1. Maternal and Pregnancy Characteristics According to Singleton Without and With Preeclampsia and Multi-Fetal Without and With Preeclampsia in First
Deliveries Among 892 425 births 1973–2010

Maternal and Pregnancy
Characteristics of First Births
1973–2010
N total 892 425

Singleton Pregnancy
Without Preeclampsia

Multi-Fetal Pregnancy

With Preeclampsia

Without Preeclampsia*

With Preeclampsia†

N

N

N

N

847 567

33 404

9935

1519
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Maternal age at delivery, y
 Mean (SD)
 Median

26.6 (5.0)

27.3 (5.3)

29.4 (5.4)

30.3 (5.5)

25.9

26.6

29.3

30.3

Maternal education, y %
 ≤9

75 421

8.9

2712

8.1

666

6.7

84

5.5

 10–12

422 996

50.1

17 307

52.0

4641

46.9

695

45.8

 >12

346 248

41.0

13 292

39.9

4600

46.4

738

48.7

 Missing

2902

Chronic hypertension, %

3211

93
0.4

220

28
0.7

62

2
0.6

7

0.5

Gestational length, d
 Mean (SD)
 Median

279.8 (13.4)

270.1 (20.6)

253.6 (23.6)

255.9 (17.4)

282

275

259

259

Preterm birth, %
 < Gestational week 37

46 506

5.5

6713

20.1

4821

48.5

749

49.3

142 794

16.9

3701

11.1

891

9.0

69

4.5

Time period of birth, %
 1973–1978
 1979–1984

171 433

20.2

6110

18.3

1291

13.0

151

9.9

 1985–1990

222 799

26.3

8655

25.9

2047

20.6

270

17.8

 1991–1995

162 083

19.1

7280

21.8

2380

24.0

376

24.8

 1996–2000

87 544

10.3

4623

13.8

1877

18.9

334

22.0

 2001–2005

47 068

5.6

2276

6.8

1121

11.3

230

15.1

 2006–2010

13 846

1.6

759

2.3

328

3.3

89

5.9

*Multi-fetal pregnancy without preeclampsia, including 251 triplets or more.
†Multi-fetal pregnancy with preeclampsia, including 42 triplets or more.
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Table 2. Additional Maternal and Pregnancy Characteristics According to Singleton Pregnancy Without and With Preeclampsia or Multi-Fetal Pregnancy Without and
With Preeclampsia in First Deliveries in the Restricted Population of 496 370 Births 1987–2010

Maternal and Pregnancy
Characteristics of First Births
1987–2010
N total=496 370

Singleton Pregnancy
Without Preeclampsia

Multi-Fetal Pregnancy

With Preeclampsia

Without Preeclampsia*

With Preeclampsia†

N

N

N

N

466 957

21 007

7180

1226

Disposable annual income around birth, %
 First tertile

96 565

20.9

4652

22.3

922

13.0

188

15.5

 Second tertile

184 807

40.0

8596

41.3

2526

35.7

451

37.2

 Third tertile

180 160

39.0

7572

36.4

3632

51.3

574

47.3

 Missing

5425

187

100

13

Reported infertility duration, y %
 No

418 751

89.7

18 357

87.4

4692

65.4

800

65.3

 1–2

24 505

5.3

1295

6.2

598

8.3

102

8.3

 3–5

16 294

3.5

873

4.2

1148

16.0

207

16.9

 >5

7407

1.6

482

2.3

742

10.3

117

9.5

80 162

17.2

2468

11.8

969

13.5

87

7.1

Daily smoker at registration

*Multi-fetal pregnancy without preeclampsia, including 223 triplets or more.
†Multi-fetal pregnancy with preeclampsia, including 37 triplets or more.
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38 years and 9 months. The overall median age at the end of
follow-up was 49.7 years (interquartile range 44.8–55.4) and
at CVD event, the median age was 48.4 years (interquartile
range 42.8–53.0). Women with multi-fetal pregnancies were
older at the time of CVD diagnosis compared with women
with singleton pregnancies (median 49.7 versus 48.3 years).
In total, 18 415 (2.1%) of the women in the study were
diagnosed with CVD during the time of follow-up (Tables 3
and 4). In women with singleton pregnancies, CVD was reported in 17 217 (2.0%) of women without preeclampsia and
1029 (3.1%) of women with preeclampsia. In women with
multi-fetal pregnancies, CVD was reported in 145 (1.5%) of
women without preeclampsia and 24 (1.6%) of women with
preeclampsia.
Variables associated with long-term risks of CVD were
preterm birth, chronic hypertension before first birth, lower
educational level, (Table 3), longer duration of infertility and
lower household disposable income, smoking (Table 4), obesity, pregestational and gestational diabetes mellitus and systemic lupus erythematosus (Table S4).
Results from the time-to-event analyses for later CVD
in births 1973 to 2010 are presented in Table 5 and Figure 2.
When adjusted for maternal age at delivery, chronic hypertension before first birth, level of education and time period
of birth, women with preeclampsia in a singleton pregnancy
had 75% higher adjusted HR for CVD compared with women
with singleton pregnancies without preeclampsia (adjusted
HR 1.75 [95% CI, 1.64–1.86]). This increased risk was not
observed among women with multi-fetal pregnancies without
preeclampsia (adjusted HR 0.94 [95% CI, 0.79–1.10]). The
hazard of CVD among women with preeclampsia in a multifetal pregnancy was not statistically different from the hazard
among women without preeclampsia in a singleton pregnancy
(adjusted HR 1.25 [95% CI, 0.83–1.86]); however, the point

estimate was further from the null value of 1, and 95% CIs
were wide.
In analyses of the restricted population giving birth 1987 to
2010, additional adjustments for household disposable income
tertile, infertility duration, and smoking in early pregnancy
were done. The results remained similar with an increased relative risk among women with singleton pregnancies and preeclampsia but not among women with multi-fetal pregnancies
without or with preeclampsia (Table 6). Additional analyses
stratified by chronic hypertension gave similar results (results
not shown).
To address the different lengths of follow-up, since multifetal pregnancies were more common in later years, we analyzed women with age at the end of follow-up <50 years and
>50 years, respectively, and results remained similar (Table
S5A and S5B and Figure 2B and 2C).

Discussion
Main Findings
In this large Swedish population-based cohort study of primiparous women, our results suggested that the risk of CVD
after a multi-fetal pregnancy with preeclampsia was not
increased compared with after a singleton pregnancy without
preeclampsia.

Interpretation
Preeclampsia phenotypes appear to be different when comparing preeclampsia in singleton and multi-fetal pregnancies.
Pregestational diabetes mellitus, infertility, and lower socioeconomic status are common cardiovascular and metabolic
risk factors for preeclampsia and CVD; and in our study, these
were confirmed risk factors for preeclampsia in singleton
pregnancies. Although they were not associated with preeclampsia in multi-fetal pregnancies. This suggests that the
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Table 3. Maternal and Pregnancy Characteristics According to Later
Compound Cardiovascular Disease Among 892 425 First Deliveries 1973–2010

Compound
Cardiovascular
Disease

Table 4. Additional Maternal and Pregnancy Characteristics According to Later
Compound Cardiovascular Disease in the Restricted Population of 496 370 First
Deliveries 1987–2010

Total

N

%

Maternal and Pregnancy
Characteristics of First
Births 1987-2010

Total

892 425

18 415

2.1

Total

Singleton

880 971

18 246

2.1

Disposable income

 Singleton without preeclampsia

847 567

17 217

2.0

 First tertile

Maternal and Pregnancy
Characteristics of First Birth
1973–2010

Compound
Cardiovascular Disease
Total

N

%

496 370

4812

1.0

102 327

984

1.0

196 380

1831

0.9

191 938

1951

1.0

5725

46

 No

442 600

4178

0.9

 Singleton with preeclampsia

33 404

1029

3.1

 Second tertile

Multi-fetal

11 454

169

1.5

 Third tertile

 Multi-fetal without
preeclampsia

9935

145

1.5

 Missing

 Multi-fetal with preeclampsia

1519

24

1.6

 1–2

26 500

266

1.0

 <30

679 245

15 615

2.3

 3–5

18 522

193

1.0

 30–34

151 638

2084

1.4

 >5

8748

175

2.0

 35–39

52 728

608

1.2

Daily smoker at registration

8814

108

1.2

 No

412 684

3226

0.8

 Yes

83 686

1586

1.9

 ≥Gestational week 37

833 636

16 761

2.0

 <Gestational week 37

58 789

1654

2.8

 ≤9

78 883

3191

4.1

 10–12

445 639

10 119

2.3

 >12

364 878

4998

1.4

2918

107

 No

888 925

18 271

2.1

 Yes

3500

144

4.1

 1973–1978

147 455

6916

4.7

 1979–1984

178 985

5274

3.0

 1985–1990

233 771

3886

1.7

 1991–1995

172 119

1561

0.9

 1996–2000

943 78

566

0.6

 2001–2005

50 695

185

0.4

 2006–2010

15 022

27

0.2

Reported infertility duration, y

Maternal age at delivery, y

 ≥40
Preterm birth

Maternal education, y
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 Missing
Chronic hypertension

Time period of birth

degree to which preeclampsia is an underlying risk profile for
CVD differs by plurality.
If all phenotypes of preeclampsia had a persistent harmful
effect on the endothelium, the long-term CVD risk would also
be present after a multi-fetal pregnancy with preeclampsia. In
this cohort, women with multi-fetal pregnancies preeclampsia
did not demonstrate an increased risk of CVD later in life
compared with women with singleton pregnancies without
preeclampsia. Furthermore, women with multi-fetal pregnancies without preeclampsia had a similar risk of later CVD as

women with singleton pregnancies, supported in earlier published data.14 This implies that women with multi-fetal pregnancies have a similar risk regarding later CVD but when
complicated by preeclampsia, the increased risk for later CVD
is not present, supporting a different underlying pathophysiology for preeclampsia in multi-fetal pregnancy. We propose
that preeclampsia in multi-fetal pregnancies might result from
increased inflammatory burden as a primary placental finding
disorder or secondary to placental hypoperfusion as a consequence of the increased burden of multi-fetal pregnancy on
the maternal cardiovascular system, rather than an underlying
cardiovascular risk profile, in line with previous published
concepts.15,24–26
Recent research has emphasized the role of the cardiovascular system in the development of preeclampsia8 and
emphasized that pregnancy can be seen as a window of opportunity to identify future risk of CVD among women developing preeclampsia.27 This data mostly applies for singleton
pregnancies and the risk of CVD after a multi-fetal pregnancy
has not been evaluated.27 The underlying hypothesis of a maladaptation of the cardiovascular system in pregnancy would
be that the placenta turns hypoxic due to an insufficient delivery of oxygen secondary to an affected cardiovascular
system and harmful molecules such as the antiangiogenic
factor sFlt-1 (soluble FMS-like tyrosine kinase-1) enter the
mothers bloodstream from the hypoxic placenta. In addition,
the angiogenic PlGF (placental growth factor) is secreted in
reduced amounts. Recent evidence has drawn interest to the
burden of a larger placenta at term and the risk of late-onset
preeclampsia in singleton pregnancies.25 The proponents
of this hypothesis suggest that such placental overcrowding
is paralleled by increased syncytiotrophoblast stress, an excessive antiangiogenic state, and ensuing excessive vascular
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Table 5. Hazard Ratios for Later Compound Cardiovascular Disease From
Maternal Age 3 Months After Delivery Among 892 425 Women With Singleton
First Deliveries Without and With Preeclampsia and Multi-Fetal First Deliveries
Without and With Preeclampsia 1973–2010

1973–2010

Unadjusted Hazard
Ratio (95% CI)

Singleton without preeclampsia

Adjusted* Hazard
Ratio (95% CI)

Ref

Ref

Singleton with preeclampsia

1.72 (1.61–1.83)

1.75 (1.64–1.86)

Multi-fetal without preeclampsia

0.84 (0.71–0.99)

0.94 (0.79–.10)

Multi-fetal with preeclampsia

1.09 (0.73–1.62)

1.25 (0.83–1.86)

*Adjusted for maternal age at delivery, chronic hypertension before first
birth, level of education, and time period of birth. Number of observations read
889 400.

inflammation. Whether the latter occurs due to a primary placental problem or secondary to maternal hypoperfusion of the
placenta remains to be determined.25,27–29

Strengths and Limitations
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A distinct strength of this study is the nation-wide population-based design including women giving birth over several
decades and a virtually complete follow-up. The large population enabled us to study the rare exposure of multi-fetal
pregnancy and preeclampsia with the outcome of CVD. The
high-quality data from several Swedish national registers
were merged, providing a unique possibility to define a cohort
without previous diagnoses of CVD and to combine information on socioeconomic status, chronic diseases, and pregnancy
data, with later diagnosis of CVD. Several important confounders were possible to consider, although some were not
available for the whole study period. Analysis on the restricted
population of births 1987 to 2010 was, therefore, performed
with similar results.
Although the comprehensiveness of the data, the quality of
the data is still a concern. Chronic hypertension could unfortunately not be included in our CVD outcomes since we cannot
assess the ICD diagnosis of chronic hypertension reliably in
the Patient Register, only including inpatient and outpatient
diagnosis received in specialized health care and not in health
centers. Thus, we would greatly underestimate the incidence
of this diagnosis in our study. To improve the accuracy of the
CVD diagnosis, one diagnosis in the inpatient, or one in outpatient and one in inpatient, or 2 diagnoses in the outpatient

register within a year was required. The CVD diagnoses in
the in-patient register have previously shown a high validity.19
Potential nondifferential misclassification of the time to CVD
event by using the ICD-8 to -10 codes could have been introduced since the outpatient register was not nation-wide until
1987, the inpatient started in 2001, and multi-fetal pregnancies
were more common in the latter years. This also implies that
a larger proportion of multi-fetal pregnancies were followed
for a shorter period of time. Furthermore, a longer follow-up
time increases the possibility of developing other risk factors
for CVD. These concerns were addressed by using maternal
age as the time scale instead of using the start of follow-up as
time zero, by adjusting for time period of birth, and for confounders as level of education that have an impact on the risk
of CVD over time. Furthermore, the results persisted in the
restricted analyses of births 1987 and 2010.
The highest level of education achieved in 2011 was used
for all women in the study population, irrespective of year of
delivery. We think that the total attained education is the optimal measure for defining maternal education as a proxy of
socioeconomic status because the intention to attain higher
education often exists in women before they give birth. With
this definition, however, women giving birth earlier during the
study period had the opportunity to attain higher education for
a longer period than women giving birth closer to the end of
the study period.
Despite the duration of the study period of >38 years, there
is a risk of right censoring. The mean age at the end of follow-up was 50 years, and there may be special circumstances
for women who are affected by CVD in early age compared
with later. This was addressed by stratified analyses of women
with age <50, and 50 years and older at the end of follow-up
were conducted showing similar results, however, analyses
were potentially hampered by lack of power (Table S5A and
S5B and Figure 2B and 2C).
Earlier studies have shown a j-shaped relationship between increasing parity and higher incidence of CVD later
in life. If women with multi-fetal pregnancies more rarely
underwent a subsequent pregnancy than women with singleton pregnancies, the total number of pregnancies among
these women will be decreased. Given that this study included a woman’s first pregnancy, any effect owing to subsequent number of pregnancies would be a mediation effect
(ie, part of the causal pathway). Therefore, we did not adjust

Figure 2. Kaplan-Meier plot for later compound cardiovascular disease. Time is presented as maternal age 3 months after delivery among. Kaplan-Meier
plot for later compound cardiovascular disease from maternal age 3 months after delivery among 892 425 women with singleton first deliveries without and
with preeclampsia and multi-fetal first deliveries without and with preeclampsia 1973–2010 (A) and stratified by women with age at the end of follow-up <50 y
(n=457 147; B) and by women with age at the end of follow-up of 50 y or older (n=435 278; C).
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Table 6. Hazard Ratios for Later Compound Cardiovascular Disease From
Maternal Age 3 Months After Delivery Among 496 370 Women With Singleton
First Deliveries Without and With Preeclampsia and Multi-Fetal First Deliveries
Without and With Preeclampsia in the Restricted Population of 1987–2010

1987–2010
Singleton without preeclampsia

Unadjusted Hazard Adjusted* Hazard
Ratio (95% CI)
Ratio (95% CI)
Ref

Ref

Singleton with preeclampsia

1.87 (1.68–2.08)

1.93 (1.73–2.15)

Multi-fetal without preeclampsia

0.80 (0.61–1.04)

0.83 (0.63–1.08)

Multi-fetal with preeclampsia

1.09 (0.62–1.92)

1.09 (0.60–1.97)

*Adjusted for maternal age at delivery, chronic hypertension before first
birth, level of education, time period of birth, income tertile close to birth,
infertility duration, and smoking in early pregnancy. Number of observations
read 490 582.
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for number of subsequent pregnancies. Furthermore, parous women without previous preeclampsia could have had
preeclampsia in a following pregnancy, potentially leading
to an increased risk of CVD, then diluting the results. The
risk of preeclampsia among nulliparous women is, however,
much higher than in parous women, and the vast majority of
women with preeclampsia in second pregnancy have a recurrence of the disease.30
The incidence of preeclampsia increased over the study
period which is also confirmed in other populations.31
Agreement between preeclampsia diagnoses in the MBR
and information in individual medical records were excellent when ICD-9 codes were used,12 and the increase is
probably not due to underreporting but rather a true increase
in the population.
Compared with singleton pregnancies, women with multifetal pregnancies have shorter median gestational length at
delivery due to increased rates of spontaneous preterm birth
and iatrogenic preterm birth due to higher incidence of preeclampsia, induction of labor according to practice, or other
circumstances such as the individual wish of the mother or
other underlying medical conditions. In Sweden, the majority
of centers recommend induction of labor at 36 to 38 weeks
in women with a multi-fetal pregnancy. This incidence corresponds to other published literature where numbers reported
range from 41%32 to 56%.33 Generally, women with multi-fetal
pregnancies, therefore, have a shorter period to develop preeclampsia than singleton pregnancies have. Preterm birth can
be considered an effect of preeclampsia in women delivered
preterm due to preeclampsia. Preterm birth in women without
preeclampsia may, however, truncate a woman’s time at risk
for developing preeclampsia (by shortening pregnancy). This
would result in a reduction of person-time at risk for the exposure of preeclampsia. Preterm birth was not included in the
adjusted analyses since it predominately was not considered a
confounding factor.

Perspectives
Women with multi-fetal pregnancies complicated by preeclampsia did not show an increased risk of CVD compared
with women without preeclampsia with singleton pregnancies. These results, and different risk factors for preeclampsia
between singleton and multi-fetal pregnancies, support the

hypothesis that, in multi-fetal pregnancies, preeclampsia might
to a larger extent be a result of increased vascular burden by
excessive inflammatory factors released from a larger and dysfunctional placenta, rather than an unfavorable cardiovascular
phenotype in the mother. If so, this has important implications
for long-term care of women, where women with multi-fetal
pregnancies complicated by preeclampsia might not be in
exaggerated risk of cardiovascular risk. It will be important
for future research to further study downstream risks of both
gestational hypertension and preeclampsia among multi-fetal
pregnancies, such as epilepsy and dementia and longer duration of follow-up for CVDs, including chronic hypertension.
This research has the potential to increase understanding of
preeclampsia cause and to more individually and optimally
tailor the long-term care of women.
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Novelty and Significance
What Is New?

•
•

Women with multi-fetal pregnancies do not exhibit an increased risk
of future cardiovascular disease compared with women with singleton
pregnancies.
The underlying pathophysiology in preeclampsia in multi-fetal pregnancy
is possibly caused by the increased burden of pregnancy rather than the
cardiovascular phenotype of the mother.

What Is Relevant?

•

The increased risk of future cardiovascular disease after preeclampsia
does not exist for women with multi-fetal pregnancies and our results

•

point to that these women might not need similar follow-up regarding
future cardiovascular disease as women with preeclampsia in singleton
pregnancies.
When allocating resources for follow-up, more effort can be directed to
women with singelton pregnancies and preeclampsia.

Summary
Women with multi-fetal pregnancies have an increased risk of preeclampsia but not an increased risk of future cardiovascular disease.

